7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...

7/1/2025Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...

7/1/2025China's STAR Market Approves Heyuan Biotech's IPO

7/1/2025China Launches New Tax Incentives to Boost Foreign Companies' Reinvest...

7/1/2025​​​​​​​Zai Lab-Backed FORTITUDE-101 Trial Hits Key Milestone in...

7/1/2025Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...

7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata

7/1/2025Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...

7/1/2025Healthgen Biotech IPO Approved, First STAR Market Biopharma Case Since...

7/1/2025NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...

7/1/2025CDE Seeks Feedback on Draft Guidelines for Pharma Changes in Cell Ther...

7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...

7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...

7/1/2025Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...

6/30/2025CDE Reopens Public Consultation on Revised Technical Guidelines for Co...

6/30/2025China's Draft National Medical Security Law: Seven Key Highlights Sign...

6/30/2025China's Pharma Market Faces Mixed Performance in Q1 2025 Amid Shifting...

6/30/2025China Medical System to Pursue Secondary Listing on Singapore Exchange

6/30/2025GenFleet IPO Highlights Promising RAS-Targeted Drug Pipeline

6/30/2025QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....

6/30/2025Conjupro Files USPTO Challenge on Ascletis' U.S. Patent for GLP‑1R Ag...

6/30/2025Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...

6/30/2025Cutia's Topical Finasteride Spray CU‑40102 Approved in China for Hair...

6/30/2025CTTQ's Anlotinib Wins Approval in China for First-Line Treatment of Ad...

Page:39/61 Total number of articles:1807: [First][<<] [37] [38] [39] [40] [41] [>>] [End]